2-(4,5-dimethylhexyl)-5-[4-(2-fluoropropan-2-yl)phenyl]-N-prop-2-enyl-3H-pyrrol-3-amine
C24H35FN2 — CID 130183110
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4,5-dimethylhexyl)-5-[4-(2-fluoropropan-2-yl)phenyl]-N-prop-2-enyl-3H-pyrrol-3-amine
2-(4,5-dimethylhexyl)-5-[4-(2-fluoropropan-2-yl)phenyl]-N-prop-2-enyl-3H-pyrrol-3-amine (PubChem CID 130183110) has the molecular formula C24H35FN2 and a molecular weight of 370.56 g/mol. Its IUPAC name is 2-(4,5-dimethylhexyl)-5-[4-(2-fluoropropan-2-yl)phenyl]-N-prop-2-enyl-3H-pyrrol-3-amine.
Molecular Properties
| Compound Name | 2-(4,5-dimethylhexyl)-5-[4-(2-fluoropropan-2-yl)phenyl]-N-prop-2-enyl-3H-pyrrol-3-amine |
|---|---|
| PubChem CID | 130183110 |
| Molecular Formula | C24H35FN2 |
| Molecular Weight | 370.56 g/mol |
| Exact Mass | 370.28 |
| IUPAC Name | 2-(4,5-dimethylhexyl)-5-[4-(2-fluoropropan-2-yl)phenyl]-N-prop-2-enyl-3H-pyrrol-3-amine |
| SMILES | C=CCNC1C=C(c2ccc(C(C)(C)F)cc2)N=C1CCCC(C)C(C)C |
| InChI | InChI=1S/C24H35FN2/c1-7-15-26-23-16-22(19-11-13-20(14-12-19)24(5,6)25)27-21(23)10-8-9-18(4)17(2)3/h7,11-14,16-18,23,26H,1,8-10,15H2,2-6H3 |
| InChIKey | PYSAIOISASSTLZ-UHFFFAOYSA-N |
| XLogP | 6.29 |
| TPSA | 24.39 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 370.56 |
| LogP ≤ 5 | 6.29 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130183110 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.